News
CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...
Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, according to a speaker at the American Diabetes Association Scientific ...
1d
MedPage Today on MSNNovel Oral GLP-1 Agent Cuts A1c, Weight in Early DiabetesAn investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with early-stage ...
It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.
A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...
Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage identification of type 1 diabetes were presented ...
Endogenex today reported positive findings from studies of its endoscopic procedure aimed at transforming diabetes care.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results